Delivery Order SPE2DB20D7066-SPE2DB25FC2AE

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,880.76, is for the delivery of ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. This is a firm fixed-price delivery order contract with an ultimate completion date of October 21, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,871.39 delivery order contract is for the provision of 4,566,518,639 ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a firm fixed price and an ultimate completion date of November 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $40,263.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4,566,769,751 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price and an ultimate completion date of December 20, 2024. Amerisourcebergen holds a significant Indefinite...
This federal contract award, valued at $4,123.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract is a Firm Fixed Price Delivery Order that runs through January 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $33,831.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4,566,518,728 tablets of Ondansetron HCL 4 mg, a medication used to treat nausea and vomiting. The contract has a Firm Fixed Price pricing type and a completion date of November 22, 2024. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,863.27, is a delivery order for 4,566,915,756 units of the drug Ondansetron ODT 4 mg tablet in 30-count packages. The contract has a firm fixed price and an ultimate completion date of January 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,893.31 firm-fixed-price delivery order is for the supply of 4,566,553,998 units of Ondansetron ODT 4 mg tablets, which are used to treat nausea and vomiting. The contract has an ultimate completion date of November 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $16,861.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of ondansetron orally disintegrating tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of December 16, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,153.36 firm fixed-price delivery order is for the supply of 4,566,677,349 units of the prescription drug Ondansetron ODT 4 mg tablet, a medication used to prevent nausea and vomiting. The contract has a total completion date of December 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,617.11 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. This contract has a completion date of December 13, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB25FC2AE
    Delivery Order

This federal contract award, valued at $13,400.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. This is a firm-fixed-price delivery order contract with a completion date of January 13, 2025. The contract does not have a set-aside designation, indicating it was awarded through open competition.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/13/25, 12:53 AM